Encompass Health Corporation (EHC) — Fair Value Analysis

Base-case fair value (P50): $104.68 · Current price: $111.07 · Verdict: Fairly Valued

The Verdict on EHC

Based on our proprietary Monte Carlo simulations, ENCOMPASS HEALTH CORP (EHC) is deemed Fairly Valued at its $111.07 level. While Monte Carlo analysis projects a median fair value (P50) of $104.68, the current market price reflects a -5.8% variance, suggesting EHC is trading near its statistically derived intrinsic worth. This assessment factors in thousands of forward-looking scenarios to provide a robust valuation against the market's current take on EHC.

How EHC stacks up against peers

EHC maintains an average quality tier, indicating its operational and financial health are in line with broader sector benchmarks. This "average" quality is a key input into our valuation model, contributing to the Fairly Valued verdict observed when comparing its $111.07 to the $104.68 fair value. The -5.8% figure, though modest, reflects that EHC's current trading level captures its inherent strengths and risks relative to this average standing.

What this means for investors

For investors, the Fairly Valued assessment means EHC's $111.07 is closely aligned with its fundamental fair value of $104.68, leaving little immediate arbitrage potential based solely on our Monte Carlo projections. The -5.8% indicates the market is efficiently pricing the company given its average quality tier. While this analysis points to a balanced current valuation, a full understanding of EHC's potential requires exploring the full range of outcomes, from bear case to bull case scenarios. Sign up for a free FairCurve account to see the complete bear and bull distribution for EHC and track its fair value as new fundamental data is released.